LANGERHANS CELL CHIMERISM AFTER MYELOABLATIVE VERSUS NON-MYELOABLATIVE HEMATOPOIETIC CELL TRANSPLANTATION

被引：0
|
作者：
Kirkorian, Y. [1 ]
Collin, M. [1 ]
Leboeuf, M. [1 ]
Bogunovic, M. [1 ]
Wood, B. [3 ]
Hackman, R. C. [2 ,3 ]
Storer, B. [2 ,3 ]
Storb, R. [2 ,3 ]
Merad, M. [3 ]
Mielcarek, M. [2 ,3 ]
机构：
[1] Mt Sinai Sch Med, New York, NY USA
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[3] Univ Washington, Seattle, WA 98195 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2009年 / 15卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2008.12.022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
15
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [1] Prevalence of chimerism after non-myeloablative hematopoietic stem cell transplantation
    Ruiz, Azulamara da Silva
    Ferrari Chauffaille, Maria de Lourdes
    Alves, Solivanda Trindade
    Rodrigues de Oliveira, Jose Salvador
    SAO PAULO MEDICAL JOURNAL, 2009, 127 (05): : 251 - 258
  • [2] Non-myeloablative hematopoietic stem cell transplantation
    Maris, M
    Sandmaier, BM
    Maloney, DG
    McSweeney, PA
    Woolfrey, A
    Chauncey, T
    Shizuru, J
    Niederwieser, D
    Blume, KG
    Forman, S
    Storb, R
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2001, 8 (03) : 231 - 234
  • [3] Renal transplantation after myeloablative and non-myeloablative hematopoietic cell transplantation from the same donor
    Tanaka, Toshiaki
    Ishida, Hideki
    Shirakawa, Hiroki
    Amano, Hiroyuki
    Nishida, Hayato
    Tanabe, Kazunari
    INTERNATIONAL JOURNAL OF UROLOGY, 2007, 14 (11) : 1044 - 1045
  • [4] Antiphospholipid syndrome after non-myeloablative hematopoietic cell transplantation
    Mata, R.
    Llamas, R.
    Roman, A.
    Prieto, E.
    Lopez, J. L.
    Tomas, J. F.
    Subira, D.
    THROMBOSIS RESEARCH, 2008, 122 (02) : 283 - 284
  • [5] Correlation between MRD and chimerism kinetics in CLL patients after myeloablative and non-myeloablative allogeneic hematopoietic stem cell transplantation
    Plesa, Adriana
    Lee, Quoc-Hung
    Revesz, Daniela
    Thomas, Xavier
    Ducastelle, Sophie
    Nicolini, Franck E.
    Michallet, Anne-Sophie
    Mollet, Isabelle
    Dubois, Valerie
    Clark, Melisa
    Dumontet, Charles
    Raus, Nicole
    Michallet, Mauricette
    BLOOD, 2007, 110 (11) : 341B - 342B
  • [6] T cell (CD3+) chimerism after non-myeloablative allogeneic hematopoietic stem cell transplantation (NMHSCT)
    Sobecks, R
    Theil, K
    Rybicki, L
    Kuczkowski, E
    Warshawsky, I
    Tubbs, R
    Kalaycio, M
    Pohlman, B
    Andresen, S
    Bolwell, BJ
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 41 - 42
  • [7] Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation
    Schiffer, Joshua T.
    Kirby, Kate
    Sandmaier, Brenda
    Storb, Rainer
    Corey, Lawrence
    Boeckh, Michael
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (08): : 1101 - 1108
  • [8] Non-myeloablative hematopoietic cell transplantation as immunotherapy for hematologic malignancies
    Mielcarek, M
    Storb, R
    CANCER TREATMENT REVIEWS, 2003, 29 (04) : 283 - 290
  • [9] Non-Myeloablative Stem Cell Transplantation
    Robert Marcus
    Bone Marrow Transplantation, 2001, 27 (6) : 667 - 667
  • [10] Correlation between MRD and chimerism kinetics in CLL patients after myeloablative and non-myeloablative allogeneic haematopoietic stem cell transplantation
    Plesa, A.
    Le, Q.
    Revesz, D.
    Thomas, X.
    Ducastelle, S.
    Nicolini, F. E.
    Michallet, A. S.
    Mollet, I.
    Dubois, V.
    Clark, M.
    Dumontet, C.
    Raus, N.
    Sobh, M.
    Michallet, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S336 - S336
12345